Confusion in pharmacies is expected to continue for a while over the lowering of the drug Betmiga (Mirabegron), an irritable bladder treatment. The pharmaceutical industry and the outpatient pharmacies predict that it will take at least a year for the drug price to be finalized.

According to the pharmaceutical industry and pharmacies on the 28th, Astellas Pharma Korea Betmiga PR will be lowered from the 1st of next month. This is because Chong Kun Dang and Hanmi Pharmaceutical succeeded in overcoming patents and released generic. The MOHW has announced that it will lower the upper limit of the original Betmiga from June 1 following the release of generic drugs.

However, it is highly likel